Clinical Trials Browser

Phase 2/3 × INDUSTRY × irinotecan sucrosofate × Clear all

NCT04037241 2022-04-01

Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases

Phase 2/3 Withdrawn

Gastrointestinal

Malignant Tumor of Pancreas Metastatic to Liver